The interferon-induced protein 3 (IFITM3), in some cases, can also prevent Zika virus from killing our cells, researchers said.
The findings, from the University of Massachusetts Medical School (UMMS) in the US, suggest that boosting the actions of IFITM3 may be useful for inhibiting Zika virus and other emerging viral infections.
"This work represents the first look at how our cells defend themselves against Zika virus' attack," said Abraham Brass, assistant professor at UMMS.
Researchers developed a suite of genomic tools to probe how human cells respond to pathogens and how these invaders exploit host cell factors and proteins to replicate.
The mosquito-transmitted Zika virus typically causes relatively mild symptoms in infected adults.
An ongoing epidemic of Zika virus began in early 2015 in Brazil and with it new evidence emerged that Zika virus infection of mothers during early pregnancy can result in microcephaly, a severe brain defect in infants.
There is no treatment for Zika virus infection. The best way to prevent the infection is to limit potential exposure to the infected mosquitoes that carry the disease.
Using the IFITM3 tools and assays they had developed for studying dengue and influenza viruses, they were able to rapidly test IFITM3's effect on Zika virus.
Found in nearly all human cells, IFITM3 works to alter the cell membrane, making it more difficult for viruses to penetrate this outer defence.
The Brass lab found that when IFITM3 levels are low, Zika virus can more readily infiltrate into the cell interior and cause infection.
Conversely, they discovered that when IFITM3 is abundant and on guard, it strongly prevents Zika virus from reaching the interior of the cell and so blocks its infection.
"We think this also reduces the levels of cell death caused by Zika virus," Savidis said.
"This work shows that IFITM3 acts as an early front line defender to prevent Zika virus from getting its hands on all of the resources in our cells that it needs to grow," said Savidis.
The study appears in the journal Cell Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
